NM_139058.3:c.613C>T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_139058.3(ARX):​c.613C>T​(p.Leu205Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000196 in 1,018,308 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L205L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000020 ( 0 hom. 0 hem. )

Consequence

ARX
NM_139058.3 missense

Scores

2
2
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.38

Publications

0 publications found
Variant links:
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
ARX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • intellectual disability, X-linked, with or without seizures, ARX-related
    Inheritance: XL Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
  • Partington syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked lissencephaly with abnormal genitalia
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • corpus callosum agenesis-abnormal genitalia syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile epileptic-dyskinetic encephalopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked spasticity-intellectual disability-epilepsy syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18035379).
BP6
Variant X-25013382-G-A is Benign according to our data. Variant chrX-25013382-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210336.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARXNM_139058.3 linkc.613C>T p.Leu205Phe missense_variant Exon 2 of 5 ENST00000379044.5 NP_620689.1 Q96QS3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARXENST00000379044.5 linkc.613C>T p.Leu205Phe missense_variant Exon 2 of 5 1 NM_139058.3 ENSP00000368332.4 Q96QS3

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
0.00000196
AC:
2
AN:
1018308
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
324762
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22917
American (AMR)
AF:
0.00
AC:
0
AN:
25719
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17513
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25326
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46124
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25474
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3050
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
809091
Other (OTH)
AF:
0.0000464
AC:
2
AN:
43094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Intellectual disability, X-linked, with or without seizures, ARX-related;C3463992:Developmental and epileptic encephalopathy, 1 Uncertain:1
Jun 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 205 of the ARX protein (p.Leu205Phe). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ARX-related conditions. ClinVar contains an entry for this variant (Variation ID: 210336). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ARX protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Feb 09, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.036
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.21
T
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.53
T
M_CAP
Pathogenic
0.49
D
MetaRNN
Benign
0.18
T
MetaSVM
Uncertain
-0.20
T
MutationAssessor
Benign
1.4
L
PhyloP100
1.4
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.60
N
REVEL
Benign
0.19
Sift
Benign
0.037
D
Sift4G
Benign
0.30
T
Polyphen
0.0010
B
Vest4
0.15
MutPred
0.14
Loss of stability (P = 0.1775);
MVP
0.80
MPC
2.0
ClinPred
0.12
T
GERP RS
2.0
Varity_R
0.097
gMVP
0.097
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs797045304; hg19: chrX-25031499; API